Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model

Ann Hepatol. 2015 Jul-Aug;14(4):540-6.

Abstract

Background: The study of NAFLD in humans has several limitations. Using murine models helps to understand disease pathogenesis.

Aim: Evaluate the impact of 4 different diets in the production of NAFLD with emphasis on a combined high-fat plus sustained high sucrose consumption.

Material and methods: Eight week-old male Wistar rats were divided in four groups and fed for 90 days with the following diets: 1) Control chow diet (C); 2) High-fat cholesterol diet (HFC) + 5% sucrose in drinking water. 3) High-fat cornstarch diet (HFCO) + 5% sucrose in drinking water. 4) Chow diet + 20% sucrose in drinking water (HSD). Metabolic changes, leptin levels, liver histology, hepatic and plasma lipid composition, fasting plasma glucose and insulin and liver gene expression of FAS, SREBP-1 and PPAR-α were evaluated.

Results: The HFC diet had the highest grade of steatosis (grade 2 of 3) and HSD showed also steatosis (grade 1). Liver weight TG and colesterol concentrations in liver were greater in the HFC diet. There were no increased levels of iron in the liver. Rats in HFC gained significantly more weight (P < 0.001). All experimental groups showed fasting hyperglycemia. HFC had the highest glucose level (158.5 ± 7 mg/dL) (P < 0.005). The HSD and the HFCO diets developed also hyperglycemia. HSD had significantly higher fasting hyperinsulinemia. Serum leptin was higher in the HFC diet (p = 0.001). In conclusion, the HFC diet with combination of high fat and high sucrose is more effective in producing NAFLD compared with a high sucrose diet only.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Diet, High-Fat*
  • Dietary Sucrose* / blood
  • Disease Models, Animal
  • Fatty Acid Synthases / genetics
  • Fatty Acid Synthases / metabolism
  • Gene Expression Regulation
  • Hyperglycemia / blood
  • Hyperglycemia / etiology
  • Hyperglycemia / genetics
  • Hyperinsulinism / blood
  • Hyperinsulinism / etiology
  • Hyperinsulinism / genetics
  • Insulin / blood
  • Iron / metabolism
  • Leptin / blood
  • Lipids / blood
  • Liver / metabolism*
  • Liver / pathology
  • Male
  • Non-alcoholic Fatty Liver Disease / blood
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / genetics
  • Non-alcoholic Fatty Liver Disease / pathology
  • PPAR alpha / genetics
  • PPAR alpha / metabolism
  • Rats, Wistar
  • Severity of Illness Index
  • Sterol Regulatory Element Binding Protein 1 / genetics
  • Sterol Regulatory Element Binding Protein 1 / metabolism
  • Time Factors
  • Weight Gain

Substances

  • Biomarkers
  • Blood Glucose
  • Dietary Sucrose
  • Insulin
  • Leptin
  • Lipids
  • PPAR alpha
  • Srebf1 protein, rat
  • Sterol Regulatory Element Binding Protein 1
  • Iron
  • Fatty Acid Synthases